JP2729545B2
(ja)
|
1991-06-05 |
1998-03-18 |
富士写真フイルム株式会社 |
ハロゲン化銀カラー写真感光材料用の処理液及びそれを用いた処理方法
|
DK152291D0
(da)
|
1991-08-28 |
1991-08-28 |
Danisco |
Fremgangsmaade og kemiske forbindelser
|
US5994629A
(en)
|
1991-08-28 |
1999-11-30 |
Novartis Ag |
Positive selection
|
RU2105005C1
(ru)
|
1992-07-03 |
1998-02-20 |
Кумиай Кемикал Индастри Ко., Лтд. |
Конденсированное гетероциклическое производное, способ его получения и гербицидное средство
|
US5852046A
(en)
|
1993-08-03 |
1998-12-22 |
Hoechst Aktiengesellschaft |
Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them
|
EP0639573A1
(de)
|
1993-08-03 |
1995-02-22 |
Hoechst Aktiengesellschaft |
Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament
|
FR2719843B1
(fr)
|
1994-05-10 |
1996-06-07 |
Synthelabo |
Dérivés de 5,6-dihydro-4h-imidazo [2',1':2,3] imidazo-[4,5,1-ij] quinoléine et de 4,5-dihydroimidazo [1,2-a] pyrrolo-[1,2,3-cd] benzimidazole, leur préparation et leur application en thérapeutique.
|
DE4441676A1
(de)
|
1994-11-23 |
1996-05-30 |
Basf Ag |
Iminooxymethylenanilide, Verfahren zu ihrer Herstellung und ihre Verwendung
|
DE19507913C2
(de)
|
1995-03-07 |
1998-04-16 |
Agfa Gevaert Ag |
Farbfotografisches Silberhalogenidmaterial
|
WO1997011065A1
(de)
|
1995-09-18 |
1997-03-27 |
Basf Aktiengesellschaft |
Phenylessigsäuren, verfahren zu ihrer herstellung und sie enthaltende mittel
|
CN1056370C
(zh)
|
1995-10-17 |
2000-09-13 |
化学工业部沈阳化工研究院 |
具有除草活性的4-芳氧(硫或氨)基嘧啶衍生物及其制备
|
US6444816B1
(en)
|
1997-10-27 |
2002-09-03 |
Dr. Reddy's Research Foundation |
Fused 7-oxo-pyrimidinyl compounds, preparation, composition and use thereof
|
WO1999026932A1
(en)
|
1997-11-26 |
1999-06-03 |
Axys Pharmaceuticals, Inc. |
By amidino group substituted heterocyclic derivatives and their use as anticoagulants
|
JPH11283746A
(ja)
|
1998-03-27 |
1999-10-15 |
Fuji Photo Film Co Ltd |
ビスベンゾアゾール化合物を用いたエレクトロルミネッセンス素子およびビスベンゾアゾール化合物の製造方法
|
WO1999061445A1
(en)
|
1998-05-22 |
1999-12-02 |
Smithkline Beecham Corporation |
G-csf mimetics
|
EP1080094A4
(en)
|
1998-05-22 |
2004-02-11 |
Smithkline Beecham Corp |
MIMETICS OF G CSF
|
US6329383B1
(en)
|
1999-01-25 |
2001-12-11 |
Pharmacia Ab |
2-amino-5-pyrimidine acetic acid compounds
|
CZ27399A3
(cs)
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
SK14372001A3
(sk)
|
1999-04-12 |
2002-06-04 |
Aventis Pharma Limited |
Substituované bicyklické heteroarylové zlúčeniny ako antagonisty integrínu a farmaceutický prostriedok, ktorý ich obsahuje
|
JP4000711B2
(ja)
|
1999-04-13 |
2007-10-31 |
東レ株式会社 |
発光素子
|
DE60015539T2
(de)
|
1999-05-05 |
2005-11-24 |
Aventis Pharma Ltd., West Malling |
Substituierte pyrrolidine als inhibitoren der zelladhäsion
|
EP1065207A1
(en)
|
1999-07-02 |
2001-01-03 |
Aventis Pharma Deutschland GmbH |
Naphthyridine derivatives, processes for their preparation, their use, and pharmaceutical compositions comprising them
|
EP1065208A1
(en)
|
1999-07-02 |
2001-01-03 |
Aventis Pharma Deutschland GmbH |
Substituted purine derivatives as inhibitors of cell adhesion
|
US6566372B1
(en)
|
1999-08-27 |
2003-05-20 |
Ligand Pharmaceuticals Incorporated |
Bicyclic androgen and progesterone receptor modulator compounds and methods
|
AU2441701A
(en)
|
1999-12-17 |
2001-06-25 |
Ariad Pharmaceuticals, Inc. |
Purine derivatives
|
US20020103161A1
(en)
|
1999-12-17 |
2002-08-01 |
Manfred Weigele |
Novel heterocycles
|
IL150062A0
(en)
|
1999-12-17 |
2002-12-01 |
Ariad Pharma Inc |
Proton pump inhibitors
|
EP1244668B1
(en)
|
2000-01-07 |
2006-04-05 |
Universitaire Instelling Antwerpen |
Purine derivatives, process for their preparation and use thereof
|
GB0004686D0
(en)
|
2000-02-28 |
2000-04-19 |
Aventis Pharma Ltd |
Chemical compounds
|
WO2001068604A2
(en)
|
2000-03-14 |
2001-09-20 |
Sepracor, Inc. |
3-substituted piperidines comprising urea functionality, and methods of use thereof
|
US6548517B2
(en)
|
2000-03-24 |
2003-04-15 |
Millennium Pharmaceuticals, Inc. |
Oxindole inhibitors of factor Xa
|
US6469026B2
(en)
|
2000-03-24 |
2002-10-22 |
Millennium Pharmaceuticals, Inc. |
Isoquinolone inhibitors of factor Xa
|
EP1341771A2
(en)
|
2000-11-29 |
2003-09-10 |
Glaxo Group Limited |
Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
|
AUPR213700A0
(en)
|
2000-12-18 |
2001-01-25 |
Biota Scientific Management Pty Ltd |
Antiviral agents
|
US6452014B1
(en)
|
2000-12-22 |
2002-09-17 |
Geron Corporation |
Telomerase inhibitors and methods of their use
|
US6693125B2
(en)
|
2001-01-24 |
2004-02-17 |
Combinatorx Incorporated |
Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders
|
WO2002076960A1
(en)
|
2001-03-22 |
2002-10-03 |
Abbott Gmbh & Co. Kg |
Transition metal mediated process
|
US20030109714A1
(en)
|
2001-03-22 |
2003-06-12 |
Neil Wishart |
Transition metal mediated process
|
WO2002102783A1
(en)
|
2001-06-19 |
2002-12-27 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
EP2336133A1
(en)
|
2001-10-30 |
2011-06-22 |
Conforma Therapeutics Corporation |
Purine analogs having HSP90-inhibiting activity
|
WO2003045929A1
(fr)
|
2001-11-26 |
2003-06-05 |
Takeda Chemical Industries, Ltd. |
Derive bicyclique, procede de production de ce derive et utilisation correspondante
|
US20040006117A1
(en)
|
2002-02-15 |
2004-01-08 |
Schering Aktiengesellschaft |
Microglia inhibitors for interrupting interleukin 12 and IFN-gamma-mediated immune reactions
|
US7071216B2
(en)
|
2002-03-29 |
2006-07-04 |
Chiron Corporation |
Substituted benz-azoles and methods of their use as inhibitors of Raf kinase
|
US8299108B2
(en)
*
|
2002-03-29 |
2012-10-30 |
Novartis Ag |
Substituted benzazoles and methods of their use as inhibitors of raf kinase
|
CN100558712C
(zh)
|
2002-06-07 |
2009-11-11 |
科蒂科股份有限公司 |
治疗分子及方法-1
|
CA2488562A1
(en)
|
2002-06-27 |
2004-01-08 |
F. Hoffmann-La Roche Ag |
Synthesis of purine derivatives
|
GB0215293D0
(en)
|
2002-07-03 |
2002-08-14 |
Rega Foundation |
Viral inhibitors
|
WO2004006849A2
(en)
|
2002-07-15 |
2004-01-22 |
Combinatorx, Incorporated |
Combinations of drugs for the treatment of neoplasms
|
JP2004067629A
(ja)
|
2002-08-09 |
2004-03-04 |
Yamanouchi Pharmaceut Co Ltd |
ミトコンドリア機能活性化剤及び新規なベンゾイミダゾール誘導体
|
AU2002951247A0
(en)
|
2002-09-06 |
2002-09-19 |
Alchemia Limited |
Compounds that interact with kinases
|
AU2003241836A1
(en)
|
2002-10-03 |
2004-04-23 |
Ono Pharmaceutical Co., Ltd. |
Lpa receptor antagonists
|
US7122665B2
(en)
|
2002-10-15 |
2006-10-17 |
Synta Pharmaceuticals Corp. |
Heterocyclic compounds
|
KR100867484B1
(ko)
|
2002-12-04 |
2008-11-06 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
1,3-디히드로이미다졸 축합 고리 화합물
|
US7531553B2
(en)
|
2003-03-21 |
2009-05-12 |
Amgen Inc. |
Heterocyclic compounds and methods of use
|
CA2520124A1
(en)
|
2003-03-28 |
2004-10-14 |
Chiron Corporation |
Use of benzazole compounds for immunopotentiation
|
US7563815B2
(en)
|
2003-05-05 |
2009-07-21 |
Merck & Co., Inc. |
Benzamidazoles, compositions containing such compounds and methods of use
|
WO2005000404A2
(en)
|
2003-05-29 |
2005-01-06 |
Synta Pharmaceuticals, Corp. |
Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss
|
DK1673349T3
(da)
|
2003-09-22 |
2010-10-25 |
S Bio Pte Ltd |
Benzimidazolderivater: fremstilling og farmaceutiske anvendelser
|
WO2005035526A1
(en)
|
2003-10-09 |
2005-04-21 |
Argenta Discovery Ltd. |
Bicyclic compounds and their therapeutic use
|
US7423150B2
(en)
|
2003-10-16 |
2008-09-09 |
Novartis Ag |
Substituted benzazoles and methods of their use as inhibitors of Raf kinase
|
US7256196B1
(en)
|
2003-12-09 |
2007-08-14 |
The Procter & Gamble Company |
Purine cytokine inhibitors
|
US20050137234A1
(en)
|
2003-12-19 |
2005-06-23 |
Syrrx, Inc. |
Histone deacetylase inhibitors
|
CA2547785A1
(en)
|
2003-12-19 |
2005-07-21 |
Merck & Co., Inc. |
Cyclic guanidines, compositions containing such compounds and methods of use
|
CN1934103B
(zh)
|
2004-03-04 |
2011-06-01 |
橘生药品工业株式会社 |
稠杂环衍生物,包含稠杂环衍生物的药物组合物及其医药用途
|
JP4528013B2
(ja)
|
2004-04-01 |
2010-08-18 |
三井化学株式会社 |
アントラセン化合物、および該アントラセン化合物を含有する有機電界発光素子
|
CA2563895C
(en)
|
2004-04-13 |
2012-10-16 |
Synta Pharmaceuticals Corp. |
Disalt inhibitors of il-12 production
|
EP1751124A4
(en)
|
2004-05-07 |
2010-04-14 |
Exelixis Inc |
RAF MODULATORS AND METHODS OF USE
|
WO2005118555A1
(en)
|
2004-06-04 |
2005-12-15 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
US7371264B2
(en)
|
2004-08-26 |
2008-05-13 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
US7371737B2
(en)
|
2004-09-09 |
2008-05-13 |
Solvay Pharmaceuticals, B.V. |
2-substituted-6-trifluoromethyl purine derivatives with adenosine-A3 antagonistic activity
|
TW200613303A
(en)
|
2004-09-09 |
2006-05-01 |
Solvay Pharm Bv |
2-substituted-6-trifluoromethyl-purine derivatives with adenosine- A3 antagonistic activity
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
JP2008517896A
(ja)
|
2004-10-21 |
2008-05-29 |
ファイザー・インク |
C型肝炎ウイルスプロテアーゼの阻害剤並びにそれを用いた組成物及び治療
|
EP1828144A2
(en)
|
2004-11-12 |
2007-09-05 |
OSI Pharmaceuticals, Inc. |
Integrin antagonists useful as anticancer agents
|
US7429608B2
(en)
|
2005-01-20 |
2008-09-30 |
Amgen Inc. |
Benzo[d]imidazol analogs as vanilloid receptor ligands and their use in treatments
|
US20090118200A1
(en)
|
2005-05-23 |
2009-05-07 |
Bergman Jeffrey M |
Proline bis-amide orexin receptor antagonists
|
WO2006128172A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating b cell regulated autoimmune disorders
|
WO2006128129A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating cancer
|
WO2006130469A1
(en)
|
2005-05-27 |
2006-12-07 |
Oregon Health & Science University |
Stimulation of neurite outgrowth by small molecules
|
WO2006138418A2
(en)
|
2005-06-14 |
2006-12-28 |
President And Fellows Of Harvard College |
Improvement of cognitive performance with sirtuin activators
|
CN101218208A
(zh)
|
2005-07-11 |
2008-07-09 |
出光兴产株式会社 |
含氮杂环衍生物以及使用其的有机电致发光元件
|
JPWO2007007463A1
(ja)
|
2005-07-11 |
2009-01-29 |
出光興産株式会社 |
電子吸引性置換基を有する含窒素複素環誘導体及びそれを用いた有機エレクトロルミネッセンス素子
|
JP2007039406A
(ja)
|
2005-08-05 |
2007-02-15 |
Idemitsu Kosan Co Ltd |
含窒素複素環誘導体及びそれを用いた有機エレクトロルミネッセンス素子
|
JP5390186B2
(ja)
|
2005-08-12 |
2014-01-15 |
ユナイテッド ステイツ ガバメント アズ レプリゼンティッド バイ ザ セクレタリー オブ ザ ユナイテッド ステイツ アーミー アンド ザ ユーエス アーミー メディカル リサーチ アンド マティリ |
広い抗菌スペクトルを有する抗菌性化合物
|
PE20070335A1
(es)
|
2005-08-30 |
2007-04-21 |
Novartis Ag |
Benzimidazoles sustituidos y metodos para su preparacion
|
US8338594B2
(en)
|
2005-12-02 |
2012-12-25 |
Bayer Healthcare Llc |
Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
|
PL1973545T3
(pl)
|
2005-12-23 |
2013-05-31 |
Ariad Pharma Inc |
Bicykliczne Związki Heteroarylowe
|
EP1976835A2
(en)
|
2006-01-13 |
2008-10-08 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
WO2007091950A1
(en)
|
2006-02-07 |
2007-08-16 |
Astrazeneca Ab |
Benzimidazoles and imidazopyridines useful in the treatment of diseases or disorders associated with cannabinoid receptor 2 (cb2) such as pain
|
US7820821B2
(en)
|
2006-02-10 |
2010-10-26 |
Transtech Pharma, Inc. |
Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors
|
EP2010530A2
(en)
|
2006-03-23 |
2009-01-07 |
Novartis AG |
Methods for the preparation of imidazole-containing compounds
|
US8063063B2
(en)
|
2006-03-23 |
2011-11-22 |
Novartis Ag |
Immunopotentiating compounds
|
MX2008013427A
(es)
|
2006-04-19 |
2008-11-04 |
Novartis Ag |
Compuestos de benzoxazole y benzotiazole sustituidos-6-0 y metodos para inhibir la señalizacion csf-1r.
|
EP2029597A4
(en)
|
2006-05-31 |
2011-11-23 |
Univ California |
purine analogs
|
US8338593B2
(en)
|
2006-07-07 |
2012-12-25 |
Gilead Sciences, Inc. |
Modulators of toll-like receptor 7
|
WO2008016666A2
(en)
|
2006-08-02 |
2008-02-07 |
Cytokinetics, Incorporated |
Certain chemical entities, compositions, and methods
|
US7635683B2
(en)
|
2006-08-04 |
2009-12-22 |
Enanta Pharmaceuticals, Inc. |
Quinoxalinyl tripeptide hepatitis C virus inhibitors
|
WO2008030584A2
(en)
|
2006-09-07 |
2008-03-13 |
Biogen Idec Ma Inc. |
Indazole derivatives as modulators of interleukin- 1 receptor-associated kinase
|
CL2007002994A1
(es)
|
2006-10-19 |
2008-02-08 |
Wyeth Corp |
Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros.
|
CA2671543A1
(en)
|
2006-12-05 |
2008-06-12 |
Chung-Ming Sun |
Indazole compounds
|
AU2007336811A1
(en)
|
2006-12-21 |
2008-07-03 |
Plexxikon, Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
WO2008086053A1
(en)
|
2007-01-03 |
2008-07-17 |
Virobay, Inc. |
Hcv inhibitors
|
WO2008124145A1
(en)
|
2007-04-05 |
2008-10-16 |
Government Of The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Steroid compounds, compositions, and methods of treatment
|
WO2008136948A1
(en)
|
2007-05-07 |
2008-11-13 |
Amgen Inc. |
Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as p38 modulators, process for their preparation, and their pharmaceutical use
|
EP2152700B1
(en)
|
2007-05-21 |
2013-12-11 |
Novartis AG |
Csf-1r inhibitors, compositions, and methods of use
|
CL2008001626A1
(es)
|
2007-06-05 |
2009-06-05 |
Takeda Pharmaceuticals Co |
Compuestos derivados de heterociclos fusionados, agente farmaceutico que los comprende y su uso en la profilaxis y tratamiento del cancer.
|
EA024359B1
(ru)
|
2007-06-29 |
2016-09-30 |
Джилид Сайэнс, Инк. |
Пуриновые производные и их применение в качестве модуляторов толл-подобного рецептора 7
|
CA2692761C
(en)
|
2007-07-12 |
2013-04-30 |
Chemocentryx, Inc. |
Fused heteroaryl pyridyl and phenyl benzenesulfonamides as ccr2 modulators for the treament of inflammation
|
WO2009011775A1
(en)
|
2007-07-13 |
2009-01-22 |
Merck & Co., Inc. |
Amidoethyl alkylamino orexin receptor antagonists
|
WO2009017954A1
(en)
|
2007-08-01 |
2009-02-05 |
Phenomix Corporation |
Inhibitors of jak2 kinase
|
AU2008287421A1
(en)
|
2007-08-10 |
2009-02-19 |
Glaxosmithkline Llc |
Nitrogen containing bicyclic chemical entities for treating viral infections
|
WO2009028629A1
(ja)
|
2007-08-29 |
2009-03-05 |
Takeda Pharmaceutical Company Limited |
複素環化合物およびその用途
|
WO2009034386A1
(en)
|
2007-09-13 |
2009-03-19 |
Astrazeneca Ab |
Derivatives of adenine and 8-aza-adenine and uses thereof-796
|
KR20100072075A
(ko)
|
2007-10-18 |
2010-06-29 |
노파르티스 아게 |
암 및 골 질환의 치료를 위한 csf-1r 억제제
|
JP2009149589A
(ja)
|
2007-12-24 |
2009-07-09 |
Dnp Fine Chemicals Co Ltd |
非対称モノアザメチンシアニンの製造方法
|
CN101239980B
(zh)
|
2008-02-18 |
2011-06-22 |
靳广毅 |
免疫受体调节剂偶联体前体和偶联体及其应用
|
PE20091838A1
(es)
|
2008-04-09 |
2009-12-18 |
Infinity Pharmaceuticals Inc |
Inhibidores de amida hidrolasa de acido graso
|
WO2010002492A1
(en)
|
2008-04-29 |
2010-01-07 |
University Of Chicago |
Methods of use of adenine derivatives for the treatment of diabetes and other disorders
|
EP2273879A4
(en)
|
2008-04-30 |
2012-03-21 |
Glaxosmithkline Llc |
PROLYLHYDROXYLASEHEMMER
|
US20100197688A1
(en)
|
2008-05-29 |
2010-08-05 |
Nantermet Philippe G |
Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancer
|
JP5595389B2
(ja)
|
2008-06-20 |
2014-09-24 |
ジェネンテック, インコーポレイテッド |
トリアゾロピリジンjak阻害剤化合物と方法
|
JO3041B1
(ar)
|
2008-07-25 |
2016-09-05 |
Galapagos Nv |
مركبات جديدة مفيدة لمعالجة الأمراض التنكسية والالتهابية
|
US9643922B2
(en)
|
2008-08-18 |
2017-05-09 |
Yale University |
MIF modulators
|
UY32138A
(es)
|
2008-09-25 |
2010-04-30 |
Boehringer Ingelheim Int |
Amidas sustituidas del ácido 2-(2,6-dicloro-fenilamino)-6-fluoro-1-metil-1h-bencimidazol-5-carboxílico y sus sales farmacéuticamente aceptables
|
EP2350044A4
(en)
|
2008-10-10 |
2012-06-06 |
Celtaxsys Inc |
PROCESS FOR INTRODUCTION OF NEGATIVE CHEMOTAXIS
|
EP2399921B1
(en)
|
2008-12-01 |
2015-08-12 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound and use thereof
|
JO3101B1
(ar)
|
2008-12-02 |
2017-09-20 |
Takeda Pharmaceuticals Co |
مشتقات بنزوثيازول كعوامل مضادة للسرطان
|
CA2787708A1
(en)
|
2009-01-22 |
2010-07-29 |
Iti Scotland Limited |
Stem cell culture methods
|
US20100204265A1
(en)
|
2009-02-09 |
2010-08-12 |
Genelabs Technologies, Inc. |
Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections
|
CN102439011B
(zh)
|
2009-02-11 |
2016-05-04 |
加利福尼亚大学校务委员会 |
Toll样受体调节剂和疾病的治疗
|
UY32470A
(es)
|
2009-03-05 |
2010-10-29 |
Boehringer Ingelheim Int |
Derivados de 2-{2-cloro-5-[(sustituido) metil]fenilamino} -1-metil]fenilamino}-1-metilbencimidazol-5-carboxamidas-n-(sustituidas) y sus sales fisiológicamente aceptables, composiciones conteniéndolos y aplicaciones
|
WO2010124097A2
(en)
|
2009-04-22 |
2010-10-28 |
Paratek Pharmaceuticals, Inc. |
Transcription factor modulating compounds and methods of use thereof
|
EP2438066A2
(en)
|
2009-06-05 |
2012-04-11 |
Cephalon, Inc. |
PREPARATION AND USES OF 1,2,4-TRIAZOLO [1,5a]PYRIDINE DERIVATIVES
|
US20120172351A1
(en)
|
2009-06-09 |
2012-07-05 |
Nobuyuki Negoro |
Novel fused cyclic compound and use thereof
|
JP6073677B2
(ja)
|
2009-06-12 |
2017-02-01 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
縮合複素環式化合物およびそれらの使用
|
KR20120093220A
(ko)
|
2009-09-16 |
2012-08-22 |
아빌라 테라퓨틱스, 인크. |
단백질 키나아제 컨쥬게이트 및 인히비터
|
EP2343297A1
(en)
|
2009-11-30 |
2011-07-13 |
Bayer Schering Pharma AG |
Triazolopyridines
|
US8486967B2
(en)
|
2010-02-17 |
2013-07-16 |
Hoffmann-La Roche Inc. |
Heteroaryl substituted piperidines
|
BR112012021652A2
(pt)
|
2010-03-04 |
2016-06-21 |
Merck Sharp & Dohme |
composto, uso do mesmo, e, composição farmacêutica
|
ES2714875T3
(es)
|
2010-03-09 |
2019-05-30 |
Dana Farber Cancer Inst Inc |
Métodos de diagnóstico y tratamiento del cáncer en pacientes que presentan o desarrollan resistencia a una primera terapia del cáncer
|
US8921545B2
(en)
|
2010-04-06 |
2014-12-30 |
University Health Network |
Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones
|
CN103601683B
(zh)
|
2010-04-16 |
2016-03-30 |
中国科学院上海药物研究所 |
苯并杂环类化合物及其制备方法和用途
|
US8815592B2
(en)
|
2010-04-21 |
2014-08-26 |
Research Development Foundation |
Methods and compositions related to dopaminergic neuronal cells
|
WO2011142381A1
(ja)
|
2010-05-11 |
2011-11-17 |
Fujita Takashi |
ベンゾ若しくはピリドイミダゾール誘導体
|
DK2571878T3
(en)
|
2010-05-17 |
2019-02-11 |
Indian Incozen Therapeutics Pvt Ltd |
Hitherto unknown 3,5-DISUBSTITUTED-3H-IMIDAZO [4,5-B] PYRIDINE AND 3,5- DISUBSTITUTED -3H- [1,2,3] TRIAZOL [4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF PROTEIN CHINES
|
CA2803620A1
(en)
|
2010-06-30 |
2012-01-05 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
WO2012016133A2
(en)
|
2010-07-29 |
2012-02-02 |
President And Fellows Of Harvard College |
Ros1 kinase inhibitors for the treatment of glioblastoma and other p53-deficient cancers
|
US8697739B2
(en)
|
2010-07-29 |
2014-04-15 |
Novartis Ag |
Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof
|
JP6075621B2
(ja)
|
2010-08-10 |
2017-02-08 |
塩野義製薬株式会社 |
新規複素環誘導体およびそれらを含有する医薬組成物
|
US8586604B2
(en)
|
2010-08-20 |
2013-11-19 |
Boehringer Ingelheim International Gmbh |
Inhibitors of the microsomal prostaglandin E2 synthase-1
|
US8759537B2
(en)
|
2010-08-20 |
2014-06-24 |
Boehringer Ingelheim International Gmbh |
3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents
|
EP2617722B1
(en)
|
2010-09-10 |
2016-03-23 |
Shionogi & Co., Ltd. |
Hetero ring-fused imidazole derivative having ampk activating effect
|
EP2640708A1
(en)
|
2010-11-19 |
2013-09-25 |
Ligand Pharmaceuticals Inc. |
Heterocycle amines and uses thereof
|
US9029343B2
(en)
|
2010-12-03 |
2015-05-12 |
Epizyme, Inc. |
Modulators of histone methyltransferase, and methods of use thereof
|
RU2013130253A
(ru)
|
2010-12-03 |
2015-01-10 |
Эпизайм, Инк. |
7-деазапуриновые регуляторы метилтрансферазы гистонов и способы их применения
|
EP2654748B1
(en)
|
2010-12-21 |
2016-07-27 |
Merck Sharp & Dohme Corp. |
Indazole derivatives useful as erk inhibitors
|
US8710082B2
(en)
|
2011-02-18 |
2014-04-29 |
Board Of Trustees Of Michigan State University |
Benzimidazole inhibition of biofilm formation
|
AU2012225382B2
(en)
|
2011-03-09 |
2016-10-27 |
Celgene Avilomics Research, Inc. |
PI3 kinase inhibitors and uses thereof
|
EP2723338A2
(en)
|
2011-06-24 |
2014-04-30 |
The Trustees of Stevens Institute of Technology |
Selective inhibitors of histone deacetylase isoform 6 and methods thereof
|
KR20140040801A
(ko)
|
2011-07-15 |
2014-04-03 |
시오노기세야쿠 가부시키가이샤 |
Ampk 활성화 작용을 갖는 아자벤즈이미다졸 유도체
|
US9868754B2
(en)
|
2011-08-08 |
2018-01-16 |
California Institute Of Technology |
Utility of nematode small molecules
|
CN103958538A
(zh)
|
2011-08-08 |
2014-07-30 |
博伊斯汤普森植物研究所 |
控制线虫的小分子化合物
|
EP2744804B1
(en)
|
2011-08-17 |
2017-05-17 |
F. Hoffmann-La Roche AG |
Inhibitors of bruton's tyrosine kinase
|
WO2013044360A1
(en)
|
2011-09-30 |
2013-04-04 |
Methylgene Inc. |
Inhibitors of protein tyrosine kinase activity
|
US20130096136A1
(en)
|
2011-09-30 |
2013-04-18 |
Methylgene Inc. |
Inhibitors of Protein Tyrosine Kinase Activity
|
US10292390B2
(en)
|
2011-11-04 |
2019-05-21 |
Wisconsin Alumni Research Foundation |
Inhibition and dispersion of bacterial biofilms with 2-aminobenzimidazole derivatives
|
JP6353788B2
(ja)
|
2012-01-13 |
2018-07-04 |
エイシア バイオサイエンシーズ インコーポレイテッド |
抗がん剤としての複素環式化合物およびその使用
|
US8889677B2
(en)
|
2012-01-17 |
2014-11-18 |
Boehringer Ingellheim International GmbH |
Substituted triazoles useful as mGlu5 receptor modulators
|
US9550763B2
(en)
|
2012-02-09 |
2017-01-24 |
Shionogi & Co., Ltd. |
Heterocyclic ring and carbocyclic derivative
|
WO2013120045A1
(en)
|
2012-02-10 |
2013-08-15 |
University Of Utah Research Foundation |
Substituted 1h-indazol-1-ol analogs as inhibitors of beta catenin/tcf protein-protein interactions
|
SG11201406185WA
(en)
|
2012-03-30 |
2014-11-27 |
Rhizen Pharmaceuticals Sa |
Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of c-met protein kinases
|
WO2013166545A2
(en)
|
2012-05-07 |
2013-11-14 |
The University Of Queensland |
6-oxopurine phosphoribosyltransferase inhibitors
|
AU2013204604B2
(en)
|
2012-05-30 |
2016-05-19 |
Biodiem Limited |
Method of treating Scedosporium spp. infection
|
CN104428293B
(zh)
|
2012-06-11 |
2018-06-08 |
Ucb生物制药私人有限公司 |
调节TNFα的苯并咪唑类
|
US9040498B2
(en)
|
2012-07-06 |
2015-05-26 |
Research Foundation Of The City University Of New York |
1,2,3-Triazolyl purine derivatives
|
TW201416354A
(zh)
|
2012-07-17 |
2014-05-01 |
Boehringer Ingelheim Int |
白三烯生成抑制劑
|
EA201590482A1
(ru)
|
2012-09-05 |
2015-07-30 |
Байер Кропсайенс Аг |
Применение замещенных 2-амидобензимидазолов, 2-амидобензоксазолов и 2-амидобензотиазолов или их солей в качестве биологически активных веществ против абиотического стресса растений
|
WO2014069426A1
(ja)
|
2012-10-31 |
2014-05-08 |
塩野義製薬株式会社 |
Ampk活性化作用を有するベンズイミダゾールおよびアザベンズイミダゾール誘導体
|
GB201220157D0
(en)
|
2012-11-08 |
2012-12-26 |
Selvita Sa |
Substitute tricyclic benzimidazoles as kinase inhibitors
|
EP2970266B1
(en)
|
2013-03-15 |
2018-01-31 |
Epizyme, Inc. |
1-phenoxy-3-(alkylamino)-propan-2-ol derivatives as carm1 inhibitors and uses thereof
|
WO2014175330A1
(ja)
|
2013-04-24 |
2014-10-30 |
塩野義製薬株式会社 |
Ampk活性化作用を有する5-オキシベンズイミダゾールおよび5-オキシアザベンズイミダゾール誘導体
|
WO2014181137A1
(en)
|
2013-05-10 |
2014-11-13 |
Karus Therapeutics Ltd |
Novel histone deacetylase inhibitors
|
CA2917667A1
(en)
|
2013-07-09 |
2015-01-15 |
Dana-Farber Cancer Institute, Inc. |
Kinase inhibitors for the treatment of disease
|
JP2016169161A
(ja)
|
2013-07-19 |
2016-09-23 |
大日本住友製薬株式会社 |
新規イミダゾピリジン化合物
|
JPWO2015056782A1
(ja)
|
2013-10-17 |
2017-03-09 |
塩野義製薬株式会社 |
新規アルキレン誘導体
|
US9828348B2
(en)
|
2013-11-08 |
2017-11-28 |
Purdue Pharma L.P. |
Benzimidazole derivatives and use thereof
|
GB201321739D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
EP3080112B1
(en)
|
2013-12-09 |
2020-06-03 |
UCB Biopharma SRL |
Imidazopyridine derivatives as modulators of tnf activity
|
GB201321748D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
GB201321744D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
GB201321741D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
US10403825B2
(en)
|
2014-02-27 |
2019-09-03 |
Universal Display Corporation |
Organic electroluminescent materials and devices
|
US9190620B2
(en)
|
2014-03-01 |
2015-11-17 |
Universal Display Corporation |
Organic electroluminescent materials and devices
|
WO2015188369A1
(en)
|
2014-06-13 |
2015-12-17 |
Merck Sharp & Dohme Corp. |
Purine inhibitors of human phosphatidylinositol 3-kinase delta
|
JP2017518339A
(ja)
|
2014-06-20 |
2017-07-06 |
インスティチュート パスツール コリア |
抗感染化合物
|
KR102657649B1
(ko)
|
2014-07-21 |
2024-04-15 |
메르크 파텐트 게엠베하 |
전자 소자용 재료
|
CN112481283A
(zh)
|
2014-07-21 |
2021-03-12 |
诺华股份有限公司 |
使用cd33嵌合抗原受体治疗癌症
|
US10059689B2
(en)
|
2014-10-14 |
2018-08-28 |
Calitor Sciences, Llc |
Substituted heteroaryl compounds and methods of use
|
JP2016079168A
(ja)
|
2014-10-17 |
2016-05-16 |
塩野義製薬株式会社 |
9員縮合環誘導体
|
JPWO2016068099A1
(ja)
|
2014-10-28 |
2017-08-10 |
塩野義製薬株式会社 |
Ampk活性化作用を有する複素環誘導体
|
JP2017537940A
(ja)
|
2014-12-10 |
2017-12-21 |
マサチューセッツ インスティテュート オブ テクノロジー |
増殖性疾患の処置に有用な融合1,3−アゾール誘導体
|
JP2016132649A
(ja)
|
2015-01-21 |
2016-07-25 |
大日本住友製薬株式会社 |
新規イミダゾピリジン誘導体およびその医薬用途
|
AU2016212526B2
(en)
|
2015-01-28 |
2020-11-05 |
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd |
Substituted imidazo (1, 2-a) pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof
|
US10696972B2
(en)
|
2015-02-19 |
2020-06-30 |
St. Jude Children's Research Hospital, Inc. |
Method for improving learning
|
CN107683279B
(zh)
|
2015-04-07 |
2020-11-03 |
广东众生睿创生物科技有限公司 |
酪氨酸激酶抑制剂及包含该酪氨酸激酶抑制剂的药物组合物
|
WO2016196991A1
(en)
|
2015-06-04 |
2016-12-08 |
Children's Hospital Medical Center |
Therapeutic targeting of myeloproliferative neoplasms by dusp1 inhibition
|
WO2016200401A1
(en)
|
2015-06-12 |
2016-12-15 |
Transitions Optical, Inc. |
Alignment compounds
|
GB2545499A
(en)
|
2015-12-18 |
2017-06-21 |
Cambridge Display Tech Ltd |
Dopant, charge transfer salt and organic electronic device
|
US10590108B2
(en)
|
2015-09-23 |
2020-03-17 |
Capella Therapeutics, Inc. |
Benzimidazoles for use in the treatment of cancer and inflammatory diseases
|
US10973913B2
(en)
|
2016-02-16 |
2021-04-13 |
Washington University |
JAK inhibitors and uses thereof
|
GB201603311D0
(en)
|
2016-02-25 |
2016-04-13 |
Jakobsson Per Johan |
New uses and methods
|
US10526345B2
(en)
|
2016-04-08 |
2020-01-07 |
Mankind Pharma Ltd. |
Compounds as GPR119 agonists
|
EP3450435A4
(en)
|
2016-04-26 |
2019-09-18 |
Shionogi & Co., Ltd |
SUBSTITUTED AZABENZIMIDAZOLE DERIVATIVE IN POSITION 5 HAVING AN AMPK ACTIVATION ACTION
|
EP3459949A4
(en)
|
2016-05-20 |
2020-04-08 |
Shionogi & Co., Ltd |
5-SUBSTITUTED BENZIMIDAZOLE DERIVATIVE AND 5-SUBSTITUTED AZABENZIMIDAZOLE DERIVATIVE WITH AMPK ACTIVATION EFFECT
|
JP7101165B2
(ja)
|
2016-08-15 |
2022-07-14 |
ニューファーマ, インコーポレイテッド |
特定の化学的実体、組成物、および方法
|
WO2018039557A1
(en)
|
2016-08-26 |
2018-03-01 |
Ngm Biopharmaceuticals, Inc. |
Methods of treating fibroblast growth factor 19-mediated cancers and tumors
|
JP7187449B2
(ja)
|
2016-09-30 |
2022-12-12 |
エピザイム,インコーポレイティド |
Ehmt2阻害剤としての置換された融合二環式または三環式複素環化合物
|
WO2018064498A1
(en)
|
2016-09-30 |
2018-04-05 |
Pairnomix, Llc |
Methods of treating epilepsy and related neurological conditions
|
JP6899993B2
(ja)
|
2016-10-04 |
2021-07-07 |
国立医薬品食品衛生研究所長 |
複素環化合物
|
JP6932394B2
(ja)
|
2016-11-11 |
2021-09-08 |
ヘポ ファーマスーティカル カンパニー リミテッド |
含窒素複素環化合物、製造方法、中間体、医薬組成物及び応用
|
DK3555070T3
(da)
|
2016-12-19 |
2023-09-18 |
Epizyme Inc |
Aminsubstituerede, heterocykliske forbindelser som ehmt2-hæmmere og fremgangsmåder til anvendelse deraf
|
US11279689B2
(en)
|
2017-01-26 |
2022-03-22 |
Araxes Pharma Llc |
1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1 yl)prop-2-en-1-one derivatives and similar compounds as KRAS G12C modulators for treating cancer
|
US20190388426A1
(en)
|
2017-01-30 |
2019-12-26 |
Université de Liège |
Perk and ire-1a inhibitors against neurodevelopmental disorders
|
US20200268753A1
(en)
|
2017-01-30 |
2020-08-27 |
Université de Liège |
Perk and ire-1a inhibitors against neurodevelopmental disorders
|
US20200113907A1
(en)
|
2017-02-20 |
2020-04-16 |
Kyoto University |
Pharmaceutical composition and treatment method for genetic disease associated with splicing abnormalities
|
FR3064268A1
(fr)
|
2017-03-23 |
2018-09-28 |
Universite De Montpellier |
Acyclonucleosides phosphonates, leurs prodrogues, et leur utilisation en tant que medicaments.
|
CA3058639A1
(en)
|
2017-03-31 |
2018-10-04 |
Epizyme, Inc. |
Methods of using ehmt2 inhibitors
|
WO2018191146A1
(en)
|
2017-04-10 |
2018-10-18 |
Navitor Pharmaceuticals, Inc. |
Heteroaryl rheb inhibitors and uses thereof
|
CN108689942B
(zh)
|
2017-04-11 |
2023-06-09 |
广东东阳光药业有限公司 |
含氮双环化合物及其制备方法和用途
|
US11738009B2
(en)
|
2017-04-18 |
2023-08-29 |
Tempest Therapeutics, Inc. |
Bicyclic compounds and their use in the treatment of cancer
|
AU2018254577B2
(en)
|
2017-04-21 |
2024-06-13 |
Epizyme, Inc. |
Combination therapies with EHMT2 inhibitors
|
AU2018258338B2
(en)
|
2017-04-26 |
2022-07-14 |
The Board Of Trustees Of The University Of Illinois |
Nrf and HIF activators/HDAC inhibitors and therapeutic methods using the same
|
US11957931B2
(en)
|
2017-04-26 |
2024-04-16 |
Yale University |
Compositions and methods for treating vitiligo
|
EP3619211A1
(en)
|
2017-05-03 |
2020-03-11 |
Université Grenoble Alpes |
Method for synthesizing diversely substituted purines
|
WO2018204765A1
(en)
|
2017-05-05 |
2018-11-08 |
Pairnomix, Llc |
Methods of treating epilepsy and kcnq2 related conditions
|
CN107383014B
(zh)
|
2017-06-21 |
2019-04-30 |
南方医科大学 |
一种1H-吡唑并[3,4-d]嘧啶类化合物及其制备方法和应用
|
CA3066939A1
(en)
|
2017-06-21 |
2018-12-27 |
SHY Therapeutics LLC |
Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
|
US10323023B2
(en)
|
2017-06-30 |
2019-06-18 |
Beijing Tide Pharmaceutical Co., Ltd. |
Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereof
|
WO2019018119A1
(en)
|
2017-07-18 |
2019-01-24 |
Pairnomix, Llc |
METHODS FOR TREATING EPILEPSY AND DISORDERS ASSOCIATED WITH KCNTI
|
EP3661496A4
(en)
|
2017-08-01 |
2021-04-21 |
Opal Biosciences Limited |
TREATMENT OF STAPHYLOCOCCAL AND ENTEROCOCCAL INFECTIONS WITH SUBSTITUTED NITROSTYRENE COMPOUNDS
|
WO2019038683A1
(en)
|
2017-08-24 |
2019-02-28 |
Institute For Stem Cell Biology And Regenerative Medicine |
COMPOUNDS TARGETING BRCA1 BRCT TANDEM DOMAINS, COMPOSITIONS AND RELATED METHODS
|
JP2020536919A
(ja)
|
2017-10-11 |
2020-12-17 |
ケモセントリックス, インコーポレイテッド |
Ccr2アンタゴニストによる巣状分節性糸球体硬化症の治療
|
US20200317642A1
(en)
|
2017-10-17 |
2020-10-08 |
Epizyme, Inc. |
Amine-substituted heterocyclic compounds as ehmt2 inhibitors and derivatives thereof
|
IL310625A
(en)
|
2017-10-18 |
2024-04-01 |
Epizyme Inc |
Methods for using EHMT2 inhibitors in the treatment or prevention of blood disorders
|
CN111343989A
(zh)
|
2017-10-18 |
2020-06-26 |
Epizyme股份有限公司 |
使用ehmt2抑制剂用于免疫疗法的方法
|
JP2021035910A
(ja)
|
2017-11-01 |
2021-03-04 |
大日本住友製薬株式会社 |
置換プリン化合物
|
KR20190064508A
(ko)
|
2017-11-30 |
2019-06-10 |
솔브레인 주식회사 |
화합물 및 이를 포함하는 유기 발광 소자
|
CN110092798A
(zh)
|
2018-01-29 |
2019-08-06 |
上海新契博生物科技有限公司 |
一种作为fgfr抑制剂的杂环化合物及其合成方法和应用
|
WO2019217838A1
(en)
|
2018-05-11 |
2019-11-14 |
The University Of Arizona |
Methods for treating or limiting development of cardiovascular disease-related neurological disorders
|
US20210330672A1
(en)
|
2018-07-13 |
2021-10-28 |
Teqla Therapeutics Inc. |
Use of bcl6 inhibitors for treating autoimmune diseases
|
CN113412259A
(zh)
|
2018-10-15 |
2021-09-17 |
紐力克斯治疗公司 |
通过泛素蛋白酶体途径降解btk的双官能化合物
|
UY38434A
(es)
|
2018-11-02 |
2020-05-29 |
Aicuris Gmbh & Co Kg |
Nuevas 6,7-dihidro-4h-pirazolo[1,5-a]pirazin indol-2-carboxamidas activas contra el virus de la hepatitis b (hbv)
|
EP3876939A4
(en)
|
2018-11-07 |
2022-08-10 |
Dana-Farber Cancer Institute, Inc. |
BENZOTHIAZOLES AND 7-AZA BENZOTHIAZOLES DERIVATIVES AS JANUS KINASE 2 INHIBITORS AND THEIR USES
|
WO2020093905A1
(zh)
|
2018-11-07 |
2020-05-14 |
四川科伦博泰生物医药股份有限公司 |
并环化合物、其制备方法及用途
|
WO2020097396A1
(en)
|
2018-11-07 |
2020-05-14 |
Dana-Farber Cancer Institute, Inc. |
Benzimidazole derivatives and aza-benzimidazole derivatives as janus kinase 2 inhibitors and uses thereof
|
US20230391768A2
(en)
|
2018-11-07 |
2023-12-07 |
Dana-Farber Cancer Institute, Inc. |
Imidazopyridine derivatives and aza-imidazopyridine derivatives as janus kinase 2 inhibitors and uses thereof
|
US20220133697A1
(en)
|
2018-12-05 |
2022-05-05 |
Aldeyra Therapeutics, Inc. |
Injectable formulations
|
IL264854A
(en)
|
2019-02-14 |
2020-08-31 |
Bahat Anat |
Spt5 inhibitors and methods of use thereof
|
CA3130767A1
(en)
|
2019-02-27 |
2020-09-03 |
The Regents Of The University Of California |
N-substituted indoles and other heterocycles for treating brain disorders
|
EP3931195A1
(en)
|
2019-03-01 |
2022-01-05 |
Revolution Medicines, Inc. |
Bicyclic heteroaryl compounds and uses thereof
|
MA55214A
(fr)
|
2019-03-05 |
2022-01-12 |
F Star Therapeutics Inc |
Composés, compositions et procédés pour le traitement d'une maladie
|
AU2020271855A1
(en)
|
2019-04-12 |
2021-11-04 |
National Health Research Institutes |
Heterocyclic compounds as kinase inhibitors for therapeutic uses
|
BR112021020055A2
(pt)
|
2019-04-12 |
2021-12-07 |
Mitobridge Inc |
Indutores de hmox1
|
WO2020243457A1
(en)
|
2019-05-29 |
2020-12-03 |
Viogen Biosciences, Llc |
Compounds and therapeutic uses thereof
|
CA3156828A1
(en)
|
2019-10-03 |
2021-04-08 |
Dana-Farber Cancer Institute, Inc. |
Tricyclic kinase inhibitors and uses thereof
|
WO2021091575A1
(en)
|
2019-11-08 |
2021-05-14 |
Nurix Therapeutics, Inc. |
Bifunctional compounds for degrading btk via ubiquitin proteosome pathway
|
BR112022010349A2
(pt)
|
2019-12-04 |
2022-08-16 |
Nurix Therapeutics Inc |
Compostos bifuncionais para degradar btk por meio de via da ubiquitina-proteossoma
|
WO2021226261A1
(en)
|
2020-05-06 |
2021-11-11 |
Ajax Therapeutics, Inc. |
6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
|
US20230099203A1
(en)
|
2020-12-23 |
2023-03-30 |
Ajax Therapeutics, Inc. |
6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
|